Skip to content

Clinical trials

Observational Hepatitis C trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Observational Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20112
20123
20141
20153
20171
20181
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Bristol-Myers Squibb2
AbbVie1
Alessandra Mangia1
Azienda Ospedaliera San Camillo Forlanini1
Centro di Riferimento Oncologico - Aviano1
European Society for Blood and Marrow Transplantation1
National Cancer Institute (NCI)1
Prof. Facchinetti Fabio1
Rigshospitalet, Denmark1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C16
Hepatitis C, Chronic5
Acquired Immunodeficiency Syndrome2
Carcinoma, Hepatocellular2
Acidosis, Lactic1
Cardiovascular Diseases1
Coinfection1
Diabetes Mellitus1
End Stage Liver Disease1
Fibrosis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.